← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Capsulomics, Llc
Baltimore, MD
$3,411,742
Total funding
4
Grants
Funding over time
peak $1.7M · FY2020–24$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,411,742 · 4
By mechanism
R44$1,806,319 · 1
R42$885,000 · 1
R41$720,423 · 2
Investigators at Capsulomics, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Validation and Early Commercialization of the ENVISAGE Assay, a Prognostic Test for Barrett's Esophagus$973,322
R44 · FY2023 · DK
An accurate, affordable, and transferable assay for minimally invasive detection of esophageal squamous cell carcinoma (ESCC) in Africa and the United States$885,000
R42 · FY2024 · CA
Validation and Early Commercialization of the ENVISAGE Assay, a Prognostic Test for Barrett's Esophagus$832,997
R44 · FY2024 · DK
Diagnosis of Esophageal Squamous Cell Carcinoma in Low-Income Countries$399,995
R41 · FY2021 · CA
A Novel Strategy for Diagnosis of Esophageal Adenocarcinoma.$250,764
R41 · FY2020 · CA
A Novel Strategy for Diagnosis of Esophageal Adenocarcinoma.$69,664
R41 · FY2020 · CA